Relapsed/Refractory Glioma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Glioma
| Record | Firm | Date |
|---|---|---|
| A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory Glioma (NCT07599371) | The First Affiliated Hospital of Zhengzhou University | 2024-10-10 |
Track Relapsed/Refractory Glioma automatically
Every clearance here is in the API, with alerts when new ones post.